These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 30252582)

  • 1. Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease.
    Ungaro F; Massimino L; Furfaro F; Rimoldi V; Peyrin-Biroulet L; D'Alessio S; Danese S
    Gut Microbes; 2019; 10(2):149-158. PubMed ID: 30252582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-Virome Analysis Sheds Light on Viral Dark Matter in Inflammatory Bowel Disease.
    Clooney AG; Sutton TDS; Shkoporov AN; Holohan RK; Daly KM; O'Regan O; Ryan FJ; Draper LA; Plevy SE; Ross RP; Hill C
    Cell Host Microbe; 2019 Dec; 26(6):764-778.e5. PubMed ID: 31757768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut virome-wide association analysis identifies cross-population viral signatures for inflammatory bowel disease.
    Tian X; Li S; Wang C; Zhang Y; Feng X; Yan Q; Guo R; Wu F; Wu C; Wang Y; Huo X; Ma X
    Microbiome; 2024 Jul; 12(1):130. PubMed ID: 39026313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut mucosal virome alterations in ulcerative colitis.
    Zuo T; Lu XJ; Zhang Y; Cheung CP; Lam S; Zhang F; Tang W; Ching JYL; Zhao R; Chan PKS; Sung JJY; Yu J; Chan FKL; Cao Q; Sheng JQ; Ng SC
    Gut; 2019 Jul; 68(7):1169-1179. PubMed ID: 30842211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
    Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
    Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overrepresentation of Enterobacteriaceae and
    Khorsand B; Asadzadeh Aghdaei H; Nazemalhosseini-Mojarad E; Nadalian B; Nadalian B; Houri H
    Front Cell Infect Microbiol; 2022; 12():1015890. PubMed ID: 36268225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
    Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteric Virome and Bacterial Microbiota in Children With Ulcerative Colitis and Crohn Disease.
    Fernandes MA; Verstraete SG; Phan TG; Deng X; Stekol E; LaMere B; Lynch SV; Heyman MB; Delwart E
    J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):30-36. PubMed ID: 30169455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
    Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
    Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-specific alterations in the enteric virome in inflammatory bowel disease.
    Norman JM; Handley SA; Baldridge MT; Droit L; Liu CY; Keller BC; Kambal A; Monaco CL; Zhao G; Fleshner P; Stappenbeck TS; McGovern DP; Keshavarzian A; Mutlu EA; Sauk J; Gevers D; Xavier RJ; Wang D; Parkes M; Virgin HW
    Cell; 2015 Jan; 160(3):447-60. PubMed ID: 25619688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic Analysis Identifies Three Reliable Biomarkers of Intestinal Inflammation in the Stools of Patients With Inflammatory Bowel Disease.
    Vitali R; Palone F; Armuzzi A; Fulci V; Negroni A; Carissimi C; Cucchiara S; Stronati L
    J Crohns Colitis; 2023 Jan; 17(1):92-102. PubMed ID: 36040453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysbiotic signatures and diagnostic potential of gut microbial markers for inflammatory bowel disease in Korean population.
    Kim HS; Oh SJ; Kim BK; Kim JE; Kim BH; Park YK; Yang BG; Lee JY; Bae JW; Lee CK
    Sci Rep; 2024 Oct; 14(1):23701. PubMed ID: 39390011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
    Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
    Front Immunol; 2022; 13():921546. PubMed ID: 35860271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gut virome in inflammatory bowel disease pathogenesis: From metagenomics to novel therapeutic approaches.
    Ungaro F; Massimino L; D'Alessio S; Danese S
    United European Gastroenterol J; 2019 Oct; 7(8):999-1007. PubMed ID: 31662858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
    Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
    Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
    Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
    Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.